![Derek Gallacher](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Derek Gallacher
Corporate Officer/Principal presso Javelin Pharmaceuticals, Inc.
Posizioni attive di Derek Gallacher
Società | Posizione | Inizio | Fine |
---|---|---|---|
Javelin Pharmaceuticals, Inc.
![]() Javelin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Javelin Pharmaceuticals, Inc. develops pharmaceutical drugs. It is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical market. The company's product candidates address the acute moderate-to-severe pain medication market segment. It has three late stage product candidates in development: Dyloject (diclofenac sodium, injectable), Rylomine (intranasal morphine) and PMI-150 (intranasal ketamine). The company was founded on February 23, 1998 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Storia della carriera di Derek Gallacher
Statistiche
Distribuzione geografica
Stati Uniti | 2 |
Posizioni
Corporate Officer/Principal | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Javelin Pharmaceuticals, Inc.
![]() Javelin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Javelin Pharmaceuticals, Inc. develops pharmaceutical drugs. It is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical market. The company's product candidates address the acute moderate-to-severe pain medication market segment. It has three late stage product candidates in development: Dyloject (diclofenac sodium, injectable), Rylomine (intranasal morphine) and PMI-150 (intranasal ketamine). The company was founded on February 23, 1998 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Derek Gallacher
- Esperienza